These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27389672)

  • 21. Qualifying Conditions Of Medical Cannabis License Holders In The United States.
    Boehnke KF; Gangopadhyay S; Clauw DJ; Haffajee RL
    Health Aff (Millwood); 2019 Feb; 38(2):295-302. PubMed ID: 30715980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. To prescribe or not to prescribe? Atypical antipsychotic drugs in patients with dementia.
    Jeste DV; Meeks T
    South Med J; 2007 Oct; 100(10):961-3. PubMed ID: 17943030
    [No Abstract]   [Full Text] [Related]  

  • 23. Haloperidol for agitation in dementia.
    Lonergan E; Luxenberg J; Colford J
    Cochrane Database Syst Rev; 2001; (4):CD002852. PubMed ID: 11687166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marijuana Patient Certification: Take Two Cookies and Call Me in the Morning.
    Deren MM
    Conn Med; 2015 Sep; 79(8):503-5. PubMed ID: 26506685
    [No Abstract]   [Full Text] [Related]  

  • 25. Medical Cannabis and School: Separating Fact From Fiction.
    Strawhacker MT
    NASN Sch Nurse; 2020 Jan; 35(1):43-48. PubMed ID: 31658906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDA Greenlights First Drug for Agitation Related to Alzheimer Disease.
    Harris E
    JAMA; 2023 Jun; 329(22):1907. PubMed ID: 37223961
    [No Abstract]   [Full Text] [Related]  

  • 27. Medical marijuana for digestive disorders: high time to prescribe?
    Gerich ME; Isfort RW; Brimhall B; Siegel CA
    Am J Gastroenterol; 2015 Feb; 110(2):208-14. PubMed ID: 25199471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy for behavioral and psychological symptoms of dementia in the elderly.
    Beier MT
    Am J Health Syst Pharm; 2007 Jan; 64(2 Suppl 1):S9-17; quiz S24-5. PubMed ID: 17215476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical Cannabis Reduced Agitation in Acquired Brain Injury: A Case Study.
    Hergert DC; Mayer AR; Hutchinson K; Sadek JR; Quinn DK
    Psychosomatics; 2020; 61(6):819-824. PubMed ID: 32111375
    [No Abstract]   [Full Text] [Related]  

  • 30. The Changing Drug Culture: Medical and Recreational Marijuana.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():11-7. PubMed ID: 26881768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia.
    Viscogliosi G; Chiriac IM; Ettorre E
    J Am Med Dir Assoc; 2017 Sep; 18(9):799-802. PubMed ID: 28739492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in U.S. Medical Cannabis Registrations, Authorizing Clinicians, and Reasons for Use From 2020 to 2022.
    Boehnke KF; Sinclair R; Gordon F; Hosanagar A; Roehler DR; Smith T; Hoots B
    Ann Intern Med; 2024 Apr; 177(4):458-466. PubMed ID: 38588545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia.
    Walther S; Mahlberg R; Eichmann U; Kunz D
    Psychopharmacology (Berl); 2006 May; 185(4):524-8. PubMed ID: 16521031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical marijuana certification for patients with sickle cell disease: a report of a single center experience.
    Curtis SA; Lew D; Spodick J; Hendrickson JE; Minniti CP; Roberts JD
    Blood Adv; 2020 Aug; 4(16):3814-3821. PubMed ID: 32790846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability in medical marijuana laws in the United States.
    Bestrashniy J; Winters KC
    Psychol Addict Behav; 2015 Sep; 29(3):639-42. PubMed ID: 26415061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacological treatment of behavioral symptoms in dementia patients].
    Gabryelewicz T
    Przegl Lek; 2014; 71(4):215-20. PubMed ID: 25141581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details.
    Pacula RL; Powell D; Heaton P; Sevigny EL
    J Policy Anal Manage; 2015; 34(1):7-31. PubMed ID: 25558490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agitation and psychosis in dementia.
    Ballard C
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
    [No Abstract]   [Full Text] [Related]  

  • 39. Medical marijuana laws and marijuana use in the USA: Any lessons?
    Chawla N; Sood M
    Natl Med J India; 2016; 29(4):220-221. PubMed ID: 28051001
    [No Abstract]   [Full Text] [Related]  

  • 40. Is the Hype of Medical Marijuana All Smoke and Mirrors?
    Koliani-Pace J; Siegel CA
    Am J Gastroenterol; 2016 Feb; 111(2):161-2. PubMed ID: 26856747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.